-transparent.png){kind=logo}
Flecainide is a benzenacetamide synthesised about a decade ago and only recently introduced into the treatment of arrhythmias. Its electrophysiological properties place it in Class IC of the anti-arrhythmia drugs. Flecainide has proved useful in the treatment of supraventricular arrhythmias, atrial fibrillation (especially in patients with Wolff-Parkinson-White disease), in reciprocating supraventricular tachycardias and in focal atrial tachycardias. The drug is also extremely effective in ventricular ectopias with a success rate of over 90%. Flecainide is therefore destined to be widely used in the treatment of arrhythmias and is indicated for both supraventricular and ventricular forms, particularly those resistant to other treatment. In addition the biological availability and long half life of Flecainide make it suitable for even very prolonged treatment.
L Croce, and
S Romano, and
L Pozzoni, and
A Lomuscio
January 1989,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
L Croce, and
S Romano, and
L Pozzoni, and
A Lomuscio
November 1985,
Nihon rinsho. Japanese journal of clinical medicine,
L Croce, and
S Romano, and
L Pozzoni, and
A Lomuscio
March 1988,
Deutsche medizinische Wochenschrift (1946),
L Croce, and
S Romano, and
L Pozzoni, and
A Lomuscio
October 1988,
Zhonghua xin xue guan bing za zhi,
L Croce, and
S Romano, and
L Pozzoni, and
A Lomuscio
June 1989,
Lancet (London, England),
L Croce, and
S Romano, and
L Pozzoni, and
A Lomuscio
December 1987,
Presse medicale (Paris, France : 1983),
L Croce, and
S Romano, and
L Pozzoni, and
A Lomuscio
September 1991,
Herz,
L Croce, and
S Romano, and
L Pozzoni, and
A Lomuscio
January 1989,
Archivos del Instituto de Cardiologia de Mexico,
L Croce, and
S Romano, and
L Pozzoni, and
A Lomuscio
May 1993,
Der Internist,
L Croce, and
S Romano, and
L Pozzoni, and
A Lomuscio
March 1994,
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
